Virpax Pharmaceuticals Inc (VRPX) - News Archive

The Dawn of a New Era in Pain Management At the intersection of medical innovation and societal need stands Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company that has set its sights on pioneering non-addictive trea...

: Virpax Pharmaceuticals, Inc. has made significant strides in the development of Probudur, a long-acting liposomal bupivacaine formulation. Recent results from a dose range finding study conducted in a minipig model in...

Virpax Pharmaceuticals Announces Encouraging Results for Probudur Amidst Financial Challenges BERWYN, Pa. In a significant step towards advancing its innovative product pipeline, Virpax Pharmaceuticals, Inc. (Nasdaq: VR...

In a significant stride toward innovative pain management solutions, Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a corporation dedicated to developing non-addictive therapeutic options for a variety of conditions inclu...

In a significant advancement for pain management, Virpax Pharmaceuticals Inc. (Nasdaq: VRPX) has announced the extension of its cooperative research and development agreement with the National Center for Advancing Trans...

Virpax Pharmaceuticals, Inc. a preclinical-stage pharmaceutical company headquartered in Berwyn, Pennsylvania, has announced the successful closing of a public offering amounting to $5.0 million. The offering included s...

BERWYN, PA Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) , a preclinical-stage pharmaceutical company renowned for its innovative and proprietary drug delivery systems aimed at treating various pain indications, has succe...

In the rapidly evolving pharmaceutical sector, the operational and financial status of companies significantly influences their market performance, investor confidence, and strategic growth potential. Virpax Pharmaceuti...

In the dynamic landscape of pharmaceutical investments, companies often experience turbulent phases shaped by regulatory compliance, funding activities, and investors’ responses to clinical trial results. An interesting...